| Abstract: | Renewed world interest in enzyme biotechnological industries now derives from the expectation that many new biocatalysts will be created by genetic engineering associated with protein engineering designer techniques, or by chemical modification of existing enzymes by use of protein tailoring methods. The biocatalysts produced are mainly enzymes, abzymes (catalytic antibodies) and synthesis (synthetic analogues or mimics), and these will be used in industry, synthesis, therapy: and in bioanalysis of components of foodstuffs, and the environment including water, air and soil. The biocatalysts, including whole cells, are firstly incorporated into a particular bioreactor form by use of enzyme engineering techniques such as immobilization, and are then used, as appropriate, to modify their substrates. Improved processing or enhanced products are thereby achieved in the case of manufacturing industry: or monitoring signals are generated, often in the form of a measurable change in current flow, in the case of environmental biosensors. Designer enzymes and cells can be made now for identified applications where the presently available biocatalysts are inadequate, incompatible or uncompetitive. |
